Prosecution Insights
Last updated: August 18, 2026

Antecip Bioventures Ii LLC

9 pending office actions • 5 art units • 7 examiners • 0 of 9 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
6
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (33%)
6
Easy (67%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (11%)
§102 only1 (11%)
Double-patenting only6 (67%)
Double-patenting + other1 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
78% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
22% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VALENROD, YEVGENY 2 72.6% +25.1%
TRAN, SUSAN T 2 62.6% +35.7%
INAM, SAHAR 1 100.0% +0.0%
MOU, LIYUAN 1 43.5% +57.7%
STEVENS, MARK V 1 65.5% +41.9%
HAVLIN, ROBERT H 1 51.6% +27.9%
BARSKY, JARED 1 50.3% +23.1%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19464471 COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS INAM, SAHAR

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17541461 BUPROPION AS A MODULATOR OF DRUG ACTIVITY BARSKY, JARED 22d overdue
19270315 PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE TRAN, SUSAN T 5d
19373642 COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS VALENROD, YEVGENY
19219972 BUPROPION AS A MODULATOR OF DRUG ACTIVITY MOU, LIYUAN
18984644 PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE STEVENS, MARK V
18778708 COMBINATION OF DEXTROMETHORPHAN AND BUPROPION FOR TREATING DEPRESSION TRAN, SUSAN T
18435115 METHOD OF MAINTAINING REMISSION OF DEPRESSIVE SYMPTOMS HAVLIN, ROBERT H
18531590 BUPROPION AS A MODULATOR OF DRUG ACTIVITY VALENROD, YEVGENY

Top Art Units

Art UnitApps
1628 3
1622 1
1615 1
1629 1
1626 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19464471 COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS INAM, SAHAR 1622 DP Non-Final OA Pending Jan 29, 2026
19373642 COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS VALENROD, YEVGENY 1628 DP Final Rejection Pending Oct 29, 2025
19270315 PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE TRAN, SUSAN T 1615 DP Non-Final OA 5d Pending Jul 15, 2025
19219972 BUPROPION AS A MODULATOR OF DRUG ACTIVITY MOU, LIYUAN 1629 §103§112DP Non-Final OA Pending May 27, 2025
18984644 PHARMACEUTICAL COMPOSITIONS COMPRISING BUPROPION AND CYSTEINE STEVENS, MARK V DP Non-Final OA Pending Dec 17, 2024
18778708 COMBINATION OF DEXTROMETHORPHAN AND BUPROPION FOR TREATING DEPRESSION TRAN, SUSAN T DP Non-Final OA Pending Jul 19, 2024
18435115 METHOD OF MAINTAINING REMISSION OF DEPRESSIVE SYMPTOMS HAVLIN, ROBERT H 1626 §102Other Final Rejection Pending Feb 07, 2024
18531590 BUPROPION AS A MODULATOR OF DRUG ACTIVITY VALENROD, YEVGENY 1628 DP Non-Final OA Pending Dec 06, 2023
17541461 BUPROPION AS A MODULATOR OF DRUG ACTIVITY BARSKY, JARED 1628 §103Other Final Rejection 22d overdue Pending Dec 03, 2021

Managing Antecip Bioventures Ii LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month